News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Exelixis, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
March 9, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the fourth quarter and year ended December 31, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Exelixis, Inc.
MORE ON THIS TOPIC
Manufacturing
With onshoring ‘having a moment,’ Aquestive CEO shares lessons from 20 years of US manufacturing
June 23, 2026
·
4 min read
·
Nick Paul Taylor
Manufacturing
How US pharma manufacturing pay stacks up to other jobs in the industry
June 23, 2026
·
1 min read
·
Gabrielle Masson
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
June 22, 2026
·
2 min read
·
Gabrielle Masson
Funding
Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assets
June 22, 2026
·
2 min read
·
Gabrielle Masson
